A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a ...

A team of Chinese scientists has used targeted gene editing to develop rice that produces coenzyme Q10 (CoQ10), a vital ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a ... and CRISPRa-UCP1 system to enable sono-gene therapy for obesity. SeqCas9, a Cas9 variant from the ...

Gene editing has for a while ... at least 1 to 3 years earlier than CRISPR Therapeutics. It has $1.1B in cash and liquid assets, with no significant debt, only long-term lease and current liabilities.

Cas enzymes are required to cut specific sections of DNA or RNA during CRISPR experiments. CRISPR is a revolutionary gene-editing tool widely used for cancer research, which is currently in the ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr (Alamy/PA) A £1.65 million treatment has been approved for use for some NHS patients ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. It works by editing the fau ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been submitted for 11 gene therapies worldwide, and 35 are in phase 3 trials, ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel ... risks associated with our capital requirements, anticipated ...